AnaBio Technologies

Executive Summary

AnaBio Technologies is a leading Irish microencapsulation company specializing in the protection and delivery of sensitive functional ingredients. Founded in 2006 and headquartered in Cork, Ireland, the company enables clients to develop next-generation health and performance products by safeguarding ingredients such as probiotics, vitamins, and omega-3s from degradation during processing, storage, and digestion. With over a decade of expertise, AnaBio’s proprietary encapsulation platforms enhance bioavailability, stability, and targeted release, serving the nutraceutical, pharmaceutical, and animal nutrition sectors. While primarily operating in the B2B space, the company’s technology addresses growing consumer demand for effective, clean-label products. As a private entity with limited public financial disclosures, AnaBio’s valuation remains undisclosed, but its niche position in the expanding microencapsulation market—projected to reach $15 billion by 2028—underscores its growth potential. The company’s ability to innovate in precision delivery positions it as a key partner for brands seeking differentiation in competitive health markets.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with Major Nutraceutical Brand70% success
• Q4 2026Launch of Novel Encapsulation Platform for Probiotics65% success
• TBDSeries A Funding Round or Grant Announcement50% success